Viewing Study NCT02551406


Ignite Creation Date: 2025-12-26 @ 3:59 PM
Ignite Modification Date: 2025-12-29 @ 6:44 AM
Study NCT ID: NCT02551406
Status: COMPLETED
Last Update Posted: 2016-02-26
First Post: 2015-09-15
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Prognostic Value of Residual Hypoventilation in Mechanically Ventilated Neuromuscular Patients
Sponsor: Centre d'Investigation Clinique et Technologique 805
Organization:

Study Overview

Official Title: Prognostic Value of Residual Hypoventilation in Mechanically Ventilated Neuromuscular Patients
Status: COMPLETED
Status Verified Date: 2016-02
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: TcCO2-VAD
Brief Summary: Different tools may be used to monitor the efficacy of home mechanical ventilation. Investigators aimed to compare the prognostic value of the different data obtained by capno-oxymetry in a mechanical ventilated neuromuscular disease's population.
Detailed Description: Home mechanical ventilation (HMV) is used to treat hypoventilation, and its efficacy is mostly assessed by daytime blood gases and nocturnal oxymetry (SpO2). Transcutaneous CO2 measure (TcCO2) has shown higher sensitivity than SpO2 to detect hypoventilation in neuromuscular diseases (NMD) patients. No data exist on the prognostic value of these techniques to monitor mechanical ventilated NMD patients.

Basing on retrospective data review, investigators aimed to compare the prognostic value of the data obtained using different tools to assess residual hypoventilation in the cohort of ventilated NMD patients followed at our reference center.

Study Oversight

Has Oversight DMC: False
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: